Blood Transfusion and Increased Perioperative Risk in Coronary Artery Bypass Grafts

Area of Science:

• Cardiovascular Surgery
• Transfusion Medicine
• Patient Outcomes Research

Background:

• Coronary artery bypass grafting (CABG) is a common cardiac procedure.
• Blood transfusions are frequently administered during CABG surgery.
• The impact of blood transfusions on clinical outcomes in CABG patients requires further investigation.

Purpose of the Study:

• To investigate the correlation between blood transfusions and clinical outcomes in patients undergoing CABG surgery.
• To assess the association of blood transfusions with composite ischemic events, infectious complications, and hospital mortality.
• To evaluate these associations in both general and low-risk patient populations.

Main Methods:

• A retrospective analysis of 1,378 patients undergoing isolated or combined CABG between 2011 and 2012.
• Collection of transfusion, clinical, and hematological data.
• Multivariate analysis to predict co-primary outcomes: composite ischemic events, composite infectious complications, and hospital mortality.
• Stratified analysis of hospital mortality in low-risk patients (logistic EuroSCORE ≤ 2%) to isolate transfusion effects.

Main Results:

• The transfusion rate among CABG patients was 63.9%.
• Blood product use was significantly associated with higher incidences of infectious complications (OR 2.67), ischemic events (OR 2.42), and hospital mortality (OR 3.07).
• Even in low-risk patients, transfused individuals showed higher rates of mortality (6% vs. 0.4%), ischemic events (11.7% vs. 24.3%), and infectious complications (6.5% vs. 12.7%).

Conclusions:

• Blood component use in CABG patients is associated with increased risks of ischemic events, infectious complications, and hospital mortality.
• These adverse associations persist even in low-risk patient populations.
• The findings suggest a potential detrimental effect of blood transfusions on outcomes following CABG surgery.